Targeting lymphotoxin depletes pathogenic T cells

Nat Med. 2009 Jul;15(7):732-3. doi: 10.1038/nm0709-732.

Abstract

A monoclonal antibody directed against lymphotoxin-α (LT-α) expressed by pathogenic T cells can prompt the clearance of these cells from the body (pages 766–773). The findings bring us one step closer to targeting only the cell populations that cause harm in autoimmune diseases while leaving beneficial arms of the immune system largely intact.

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy*
  • Humans
  • Interleukin-17 / physiology*
  • Lymphocyte Depletion*
  • Lymphotoxin-alpha / antagonists & inhibitors*
  • Th1 Cells / immunology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Interleukin-17
  • Lymphotoxin-alpha
  • Tumor Necrosis Factor-alpha